New BRD Antibiotic Launches In September

GLOBAL - Merck Animal Health is hosting a symposium and reception to launch ZUPREVO® (tildipirosin) — a novel antibiotic for the treatment and prevention of bovine respiratory disease (BRD).
calendar icon 11 August 2011
clock icon 1 minute read

MSD Animal Health - NYSE:MRK

The product is expected to be available in 18 EU states in the next few months and in the US and Canada in 2012.

The symposium and reception will take place on the seventh September, 18:30, at the sixth European Congress of Bovine Health Management, Palais de Congrès in Liege, Belgium.

Speaking at the event are:

  • Prof Stephen Douthwaite - Professor of Molecular Microbiology, University of Southern Denmark, Odense
  • Prof Kerstin Mueller - Department Head, Ruminant Clinic, Free University of Berlin
  • Dr Peter Schmid - Managing Director and Global Head of Drug Discovery, MSD Animal Health
  • Dr Rainer Roepke - Global Project Manager, MSD Animal Health
  • Dr Markus Rose - Senior Development Manager, MSD Animal Health
  • Dr Nadja Rohdich - Clinical Research Manager, MSD Animal Health

Seating is limited, so please RSVP to Meghan Feeks ([email protected]) by Monday, 29 August, and let her know the names of representatives from your organisation who will be attending.

(For information about press registrations at ECBHM, please visit

TheCattleSite News Desk More MSD Animal Health News
© 2000 - 2024 - Global Ag Media. All Rights Reserved | No part of this site may be reproduced without permission.